Immune Checkpoint B7-H3 Is a Therapeutic Vulnerability in Prostate Cancer Harboring PTEN and TP53 Deficiencies

Researchers sought in vivo genetic evidence for, and mechanistic understanding of, the role of B7 homolog 3 protein (B7-H3) in PTEN/TP53-deficient prostate cancer.
[Science Translational Medicine]
AbstractPress Release

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News